Skip to main content
Daily Report

Daily Ards Research Analysis

07/07/2026
3 papers selected
14 analyzed

Analyzed 14 papers and selected 3 impactful papers.

Summary

Analyzed 14 papers and selected 3 impactful articles.

Selected Articles

1. Pros and Cons of Positive End-Expiratory Pressure Titration Guided by Electrical Impedance Tomography in Patients with Acute Respiratory Distress Syndrome: A Meta-Analysis.

68.5Level IIMeta-analysis
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP · 2026PMID: 42403132

Across 12 studies, EIT-guided PEEP titration did not change oxygenation, compliance, or ICU stay relative to traditional methods but was associated with significantly lower mortality (OR 0.59) and a small reduction in mean arterial pressure. These findings suggest EIT may improve outcome by optimizing regional ventilation/overdistension balance beyond conventional metrics.

Impact: Demonstrates a mortality signal for a bedside, noninvasive imaging-guided ventilation strategy in ARDS, potentially informing practice and trial design.

Clinical Implications: Where available, consider EIT to guide PEEP titration while closely monitoring hemodynamics. Randomized trials are needed before guideline changes, but this supports integrating regional ventilation mapping into decision-making.

Key Findings

  • Included 12 studies comparing EIT-guided versus traditional PEEP titration in ARDS.
  • No significant differences in PEEP level, oxygenation index, lung compliance, ICU length of stay, or APACHE II.
  • Lower mortality with EIT-guided titration (OR 0.59, p = 0.03).
  • Mean arterial pressure was lower in EIT-guided group (SMD = -0.28, p = 0.03).

Methodological Strengths

  • Systematic search across major databases with quantitative synthesis.
  • Assessed multiple clinically meaningful endpoints including mortality and hemodynamics.

Limitations

  • Heterogeneity in included study designs and EIT titration protocols.
  • Proportion of randomized trials and risk of bias not fully detailed; potential publication bias.

Future Directions: Conduct adequately powered RCTs with standardized EIT-guided protocols to confirm mortality benefit and define hemodynamic safety thresholds.

This study explored the effectiveness of an electrical impedance tomography (EIT)-based positive end-expiratory pressure (PEEP) titration strategy compared with traditional methods in patients with acute respiratory distress syndrome (ARDS). A systematic search of the literature was conducted through PubMed, Embase, and the Cochrane Library, resulting in the inclusion of 12 relevant studies. The results showed no significant differences between the EIT group and the traditional group with respect to PEEP levels, oxygenation index, lung compliance, ICU length of stay, or APACHE II scores. However, the mortality rate in the EIT group was significantly lower than that in the traditional group (OR = 0.59, p = 0.03), and their mean arterial pressure was also lower (SMD = -0.28, p = 0.03). Therefore, the EIT-guided PEEP titration protocol demonstrates superior mortality outcomes compared to traditional methods. Key Words: Electrical impedance tomography, Positive end-expiratory pressure, acute respiratory distress syndrome.

2. Biomarkers for Pediatric Acute Respiratory Distress Syndrome: A Systematic Review.

64Level IISystematic Review
Journal of inflammation research · 2026PMID: 42404003

This systematic review included 9 studies (n=759) and identified nine PARDS biomarkers spanning epithelial, endothelial, inflammatory, and stress-response pathways. Six biomarkers showed strong diagnostic/predictive performance (AUC > 0.80), highlighting candidates to augment PARDS recognition and risk stratification pending validation.

Impact: Provides an organized, mechanism-based map of PARDS biomarkers with quantified performance, addressing a major gap in early pediatric ARDS identification.

Clinical Implications: Biomarker panels may complement clinical criteria to facilitate earlier PARDS detection and prognosis assessment, but routine use awaits multicenter, prospective validation and standardization of sampling and thresholds.

Key Findings

  • Screened 4,889 records; included 9 studies with 759 critically ill children (median age 1.8–14.7 years).
  • Identified nine biomarkers across four mechanisms: epithelial injury (CC16), stress response (Glypican-4, nucleosomes), inflammatory (Gal-3BP, miR-424, miR-21, HBP, PGRN), and endothelial injury (VWF).
  • Six biomarkers demonstrated AUC > 0.80 for diagnosis/prediction; three showed moderate performance (AUC 0.60–0.80).

Methodological Strengths

  • Comprehensive multi-database search including Western and Chinese databases.
  • Study quality assessed using Revised Newcastle-Ottawa Scale and QUADAS-2.

Limitations

  • Only nine studies with heterogeneous designs, timing of sampling, and PARDS definitions.
  • Potential publication bias; limited external validation and standardization.

Future Directions: Prospective, multicenter validation of top-performing biomarkers with standardized protocols; exploration of multiplex panels and integration with clinical scores and imaging.

OBJECTIVE: Pediatric acute respiratory distress syndrome (PARDS) is a common and severe complication in critically ill children, significantly impacting both short-term and long-term outcomes. Diagnosis currently relies on the Berlin definition; however, the applicability of existing diagnostic criteria across different clinical settings remains challenging, particularly in pediatric populations, hindering early recognition and clinical implementation. Biomarkers have demonstrated potential in PARDS diagnosis, prediction, and prognosis assessment, but a systematic synthesis of existing evidence remains lacking. METHODS: We systematically searched PubMed, Cochrane Library, Embase, Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang Database, VIP Database, SinoMed, and Scopus from their inception to September 12, 2025. Study quality was assessed using the Revised Newcastle-Ottawa Scale and the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2). Data extraction included study characteristics, biomarker names, research objectives, sample types, sampling time points, biomarker types, PARDS diagnostic criteria, and outcome measures. RESULTS: A total of 4889 publications were screened, with 9 studies of moderate to high quality (score >6) ultimately included, involving 759 critically ill children (median age range: 1.8-14.7 years; 641 [63.8%] male). Nine biomarkers were identified and categorized into four mechanisms: epithelial injury (CC16), stress response (Glypican-4, nucleosomes), inflammatory response (Gal-3BP, miR-424, mirR-21, HBP, PGRN), and endothelial injury (VWF). Six biomarkers demonstrated strong predictive and diagnostic capabilities (AUC > 0.80), while the remaining three showed moderate efficacy (AUC 0.60-0.80). CONCLUSION: Although the nine biomarkers demonstrate potential in PARDS assessment, their clinical utility remains inconsistent. Future large-scale, multicenter prospective validation studies are needed. Combining advanced technologies to optimize existing biomarkers and explore new candidates will enhance the prediction, diagnosis, and management of PARDS.

3. Impact of Visceral Fat on Oxygenation Response to Prone Positioning in Mechanically Ventilated Patients With Severe COVID-19.

43Level IIICohort
Cureus · 2026PMID: 42403846

In 89 ventilated severe COVID-19 patients, automatically quantified visceral fat modified oxygenation response to prone positioning: patients with lower VF had greater P/F improvement during proning, with no difference after returning supine and no ECMO differences. This suggests body composition may inform expectations and selection for prone therapy.

Impact: Identifies a readily quantifiable imaging biomarker (visceral fat) that modifies physiologic response to a guideline-recommended ARDS therapy.

Clinical Implications: Consider baseline VF assessment to set expectations for oxygenation gains during proning and to tailor supportive strategies; findings should not preclude proning in high-VF patients but warrant prospective validation.

Key Findings

  • Retrospective cohort of 89 ventilated severe COVID-19 patients receiving prone therapy.
  • Visceral fat quantified automatically from admission chest CT and dichotomized at 100 cm².
  • Greater P/F ratio during proning in low-VF vs high-VF groups (279 vs 228; p = 0.016); interaction significant during proning.
  • No group differences after returning supine and no differences in ECMO initiation.

Methodological Strengths

  • Objective, automated VF quantification from CT imaging.
  • Multilevel modeling with interaction term and covariate adjustment across multiple time points.

Limitations

  • Single-center, retrospective design with modest sample size limits causal inference and generalizability.
  • COVID-19-specific cohort; outcomes focused on oxygenation, not mortality or ventilator-free days.

Future Directions: Prospective studies to validate VF as an effect modifier for prone response, evaluate outcome benefits, and assess bedside surrogates (e.g., ultrasound, anthropometrics).

Background Prone positioning therapy is internationally recommended as a cost-effective method to improve oxygenation and reduce mortality in patients with severe acute respiratory distress syndrome. This study investigated whether visceral fat (VF) area is associated with changes in oxygenation during prone positioning in mechanically ventilated patients with severe COVID-19 pneumonia. We further assessed whether VF modifies the magnitude of the oxygenation response to prone positioning. Methods We conducted a retrospective observational study of 89 critically ill COVID-19 patients who received mechanical ventilation and prone positioning therapy at a university hospital from April 2020 to November 2021. VF area was automatically quantified from admission chest CT, and patients were classified into high and low VF groups using a 100 cm² cutoff. The primary outcome was the ratio of the partial pressure of oxygen in arterial blood (PaO2) and fraction of inspiratory oxygen (FiO2) (P/F ratio) at four time points. Secondary outcomes included extracorporeal membrane oxygenation (ECMO) use. A multilevel analysis was performed to determine if VF area modified the therapy's effectiveness, adjusting for covariates. An interaction term was included to assess whether the effect of prone positioning on oxygenation differed by VF level. Results Among 89 patients, baseline P/F ratios were similar between the low and high VF groups (147 vs 138). During prone positioning, oxygenation improved in both groups, and the low VF group showed a significantly higher P/F ratio than the high VF group (279 vs 228; p = 0.016). Interaction analysis showed that the difference in P/F ratios between groups was significantly greater during the prone positioning phase, suggesting that prone positioning amplified the effect of VF on oxygenation. This difference was no longer observed after returning to the supine position (181 vs 195). No significant differences were observed in ECMO use between the groups. Conclusion In severe COVID-19 pneumonia, the low VF group experienced significantly better oxygenation during prone positioning than the high VF group, with the difference being more pronounced during the prone phase. This difference was not observed after returning to the supine position. Prone positioning did not reduce the probability of ECMO initiation. Future studies should evaluate whether VF assessment can guide individualized prone positioning strategies and improve outcome-oriented patient selection.